The following overview of terminology can be helpful for patients that are inexperienced or new to medical cannabis
Cannabinoids are the chemical compounds unique to cannabis that act upon the human body’s cannabinoid receptors. There are over 80 known cannabinoids present in the Cannabis plant, each with varying effects.
Terpenes are a class of organic compounds present in a variety of plants, including Cannabis. Different strains can be distinguished by the variety of terpenes they produce, which contributes to differences in aroma, flavour and effects. Terpenes and terpenoids are the primary constituents of the essential oils of many types of plants and flowers
Trichomes are the resin production glands of the cannabis plant. They contain the highest concentration of cannabinoids in the plant.
THC is the primary psychoactive constituent present in medical marijuana, commonly related to the euphoric effects or “high” from marijuana
CBD is the second most prevalent cannabinoid in Cannabis after THC. Research has shown that CBD provides a therapeutic effect without contributing to the psychoactive “high”
Hybrid cannabis plants are a genetic cross between two or more separate strains of cannabis, exhibiting characteristics of both. Plants can be balanced or Sativa-dominant and Indica-dominant hybrids.
A strain is a specific variety of medical cannabis, with a unique cannabinoid and terpene profile that contributes to its specific effects.
A vaporizer is a device used to inhale cannabis without combusting it. Vaporizers work by heating the dried cannabis matter to a temperature below the burning point that produces a cannabinoid-rich vapour that can be inhaled directly.
Call 1-844-644-4726 (1-844-OGI-GRAM) and the folks on our client support team like Nicole, Bhreagh and Jastine can answer any question you have.
Monday to Thursday: 8:30 AM to 8:00 PM
Friday: 8:30 AM to 6:30 PM
Interested in keeping up with Organigram news? Subscribe to our mailing lists and stay up-to-date on Organigram products, patient programs, company news and investor relations.
If you wish to receive newsletters from Organigram Holdings Inc. and its subsidiaries, please provide your email address and click on the “Subscribe” button above. If we do not receive your consent, we may be unable to send you communications. If you have any questions, or if you wish to withdraw your consent at any time, please feel free to contact us by phone at 1-844-644-4726 or by email at email@example.com. By clicking “Subscribe” I consent to receipt of communications as indicated above.